N-[3-[5-(2-hydroxy-2-methylpropoxy)-2-pyridinyl]-1-methylpyrazol-4-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide
C21H22N6O4 — CID 122638821
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-[5-(2-hydroxy-2-methylpropoxy)-2-pyridinyl]-1-methylpyrazol-4-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide
N-[3-[5-(2-hydroxy-2-methylpropoxy)-2-pyridinyl]-1-methylpyrazol-4-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide (PubChem CID 122638821) has the molecular formula C21H22N6O4 and a molecular weight of 422.45 g/mol. Its IUPAC name is N-[3-[5-(2-hydroxy-2-methylpropoxy)-2-pyridinyl]-1-methylpyrazol-4-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide.
Molecular Properties
| Compound Name | N-[3-[5-(2-hydroxy-2-methylpropoxy)-2-pyridinyl]-1-methylpyrazol-4-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide |
|---|---|
| PubChem CID | 122638821 |
| Molecular Formula | C21H22N6O4 |
| Molecular Weight | 422.45 g/mol |
| Exact Mass | 422.17 |
| IUPAC Name | N-[3-[5-(2-hydroxy-2-methylpropoxy)-2-pyridinyl]-1-methylpyrazol-4-yl]-5-(1H-pyrazol-4-yl)furan-2-carboxamide |
| SMILES | Cn1cc(NC(=O)c2ccc(-c3cn[nH]c3)o2)c(-c2ccc(OCC(C)(C)O)cn2)n1 |
| InChI | InChI=1S/C21H22N6O4/c1-21(2,29)12-30-14-4-5-15(22-10-14)19-16(11-27(3)26-19)25-20(28)18-7-6-17(31-18)13-8-23-24-9-13/h4-11,29H,12H2,1-3H3,(H,23,24)(H,25,28) |
| InChIKey | WPTXXHCBOMAVOA-UHFFFAOYSA-N |
| XLogP | 2.87 |
| TPSA | 131.09 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 422.45 |
| LogP ≤ 5 | 2.87 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122638821 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.